FDA Inspection 818450 - James G Cole Inc dba ASN/Maxam Neutraceutics - February 11, 2013

FDA Inspection 818450 for James G Cole Inc dba ASN/Maxam Neutraceutics on February 11, 2013. Classification: Official Action Indicated (OAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 818450 for James G Cole Inc dba ASN/Maxam Neutraceutics on February 11, 2013. Classification: Official Action Indicated (OAI).

Violation Codes

21 CFR 111.130(b)

21 CFR 111.16

21 CFR 111.160(d)(2)

21 CFR 111.205(a)

21 CFR 111.210(d)

21 CFR 111.210(f)

21 CFR 111.210(h)(3)

21 CFR 111.210(h)(5)

21 CFR 111.260(c)

21 CFR 111.260(d)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

James G Cole Inc dba ASN/Maxam Neutraceutics

Inspection Date

February 11, 2013

Product Type

Food/Cosmetics

ID: ff35e7ba-5f1b-4576-a07e-e2833d32fd61

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox